Human Monocyte-Derived Osteoclasts Are Targeted by Staphylococcal Pore-Forming Toxins and Superantigens.

PLoS One

Centre International de Recherche en Infectiologie, INSERM U1111, Pathogenesis of staphylococcal infections, University of Lyon 1, Department of Clinical Microbiology, Northern Hospital Group, Hospices Civils de Lyon, 103 grande rue de la Croix Rousse, 69004 Lyon, France.

Published: July 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Staphylococcus aureus is the leading cause of bone and joint infections (BJIs). Staphylococcal pathogenesis involves numerous virulence factors including secreted toxins such as pore-forming toxins (PFTs) and superantigens. The role of these toxins on BJI outcome is largely unknown. In particular, few studies have examined how osteoclasts, the bone-resorbing cells, respond to exposure to staphylococcal PFTs and superantigens. We investigated the direct impact of recombinant staphylococcal toxins on human primary mature monocyte-derived osteoclasts, in terms of cytotoxicity and cell activation with cell death and bone resorption assays, using macrophages of the corresponding donors as a reference. Monocyte-derived osteoclasts displayed similar toxin susceptibility profiles compared to macrophages. Specifically, we demonstrated that the Panton-Valentine leukocidin, known as one of the most powerful PFT which lyses myeloid cells after binding to the C5a receptor, was able to induce the death of osteoclasts. The archetypal superantigen TSST-1 was not cytotoxic but enhanced the bone resorption activity of osteoclasts, suggesting a novel mechanism by which superantigen-producing S. aureus can accelerate the destruction of bone tissue during BJI. Altogether, our data indicate that the diverse clinical presentations of BJIs could be related, at least partly, to the toxin profiles of S. aureus isolates involved in these severe infections.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774977PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150693PLOS

Publication Analysis

Top Keywords

monocyte-derived osteoclasts
12
pore-forming toxins
8
pfts superantigens
8
bone resorption
8
osteoclasts
6
toxins
5
human monocyte-derived
4
osteoclasts targeted
4
staphylococcal
4
targeted staphylococcal
4

Similar Publications

models aim to recapitulate human physiological processes, improving upon and replacing the need for animal-based models. Modeling bone formation via endochondral ossification is a very complex process due to the large number of cell types involved. Most current models are limited to mimicking the initial stages of the process (i.

View Article and Find Full Text PDF

People with HIV (PWH) have an increased risk of developing cardiovascular disease (CVD). Our recent data demonstrated that the multi-isoform proinflammatory cytokine IL-32 is upregulated in PWH and is associated with arterial stiffness and subclinical atherosclerosis. However, the mechanisms by which IL-32 contributes to the pathogenesis of these diseases remain unclear.

View Article and Find Full Text PDF

Boosting mRNA-Engineered Monocytes via Prodrug-Like Microspheres for Bone Microenvironment Multi-Phase Remodeling.

Adv Healthc Mater

March 2025

Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, P. R. China.

Monocytes, as progenitors of macrophages and osteoclasts, play critical roles in various stages of bone repair, necessitating phase-specific regulatory mechanisms. Here, icariin (ICA) prodrug-like microspheres (ICA@GM) are developed, as lipid nanoparticle (LNP) transfection boosters, to construct mRNA-engineered monocytes for remodeling the bone microenvironment across multiple stages, including the acute inflammatory and repair phases. Initially, ICA@GM is prepared from ICA-conjugated gelatin methacryloyl via a microfluidics system.

View Article and Find Full Text PDF

Epithelial RANKL Limits Experimental Periodontitis via Langerhans Cells.

J Dent Res

November 2024

Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University, Jerusalem, Israel.

Article Synopsis
  • - RANKL is identified as a key player in periodontitis, primarily influencing osteoclast differentiation and acting as a link between bone and the immune system, showcasing a complex role beyond its initial recognition as an activator of dendritic cells (DCs).
  • - In studies using ligature-induced periodontitis (LIP), rapid bone loss was observed, which eventually stopped despite the presence of the ligature, indicating a connection to immunosuppressive conditions in the gingiva associated with T regulatory (Treg) cell expansion.
  • - Experiments with K14-RANKL mice, which overexpress RANKL in gingival cells, revealed that increased RANKL leads to a favorable balance of immune cells
View Article and Find Full Text PDF

An improved understanding of pediatric chronic nonbacterial osteomyelitis pathophysiology informs current and future treatment.

J Bone Miner Res

October 2024

Department of Women's & Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.

Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disease that primarily affects children and young people. It can cause significant pain, reduced function, bone swelling, and even (vertebral body) fractures. Because of a limited understanding of its pathophysiology, the treatment of CNO remains empiric and is based on relatively small case series, expert opinion, and personal experience.

View Article and Find Full Text PDF